Dr. McNamara is director of the Lipidomics Research Program, which investigates the role of fatty acids in the pathoetiology and treatment of recurrent neuropsychiatric disorders using animal models, postmortem brain tissue, and preclinical and clinical neuroimaging techniques. His lab is currently investigating the effects of omega-3 fatty acid supplementation on functional brain activation patterns and symptom severity in children and adolescents with or at high risk for mood disorders associated with elevated inflammation, including major depressive disorder and bipolar disorder. Dr. McNamara has more than 100 peer-reviewed publications.